Article

CK induces morphological changes on histological study

Conductive keratoplasty (CK) produced collagen shrinkage changes in human corneas that were localized to 80% of the stromal depth compared with normal control corneas, according to Tatiana Naoumidi, MD.

Paris—Conductive keratoplasty (CK) produced collagen shrinkage changes in human corneas that were localized to 80% of the stromal depth compared with normal control corneas, according to Tatiana Naoumidi, MD.

Dr. Naoumidi and colleagues of the University of Crete Medical School, Greece, applied three CK spots to one cornea of 6 patients with peripheral keratoconus, all of whom had had penetrating keratoplasty (PK). The spots were applied in the periphery of the cornea; corneal buttons were assessed 1 and 3 days and 1, 3, and 6 month after the procedure.

Dr. Naoumidi reported at the annual meeting of the European Society of Cataract and Refractive Surgeons that on Days 1 and 3 after CK, there were small areas of detachment observed between the basal layer of the epithelial cells and Bowman's layer, which corresponded to the area that the top penetrated. On Day 7, the appearance of the epithelium was almost normal.

In all the corneal samples studied, the collagen layers had a crumpled appearance in up to 80% of the stromal depth and the affected area was cylindrical in shape with a diameter of 120 µm. Folds in Descemet's membrane between the CK spots were seen up to 6 months after the procedure.

"We found CK to be safe and efficient in that it caused changes in the corneal collagen that could be described as crumpled layers of collagen. The application reached the depth of 80% of the corneal thickness and the results were stable through the 6-month period of observation. The damage to the surrounding tissue was minimal," she concluded.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.